Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitos MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Atos Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimitos MV 1mg/500mg/0.2mg Tablet

Glimitos MV 1mg/500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. This medication helps regulate blood glucose in diabetic patients. Administer Glimitos MV 1mg/500mg/0.2mg tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan that includes a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Maintain regular mealtimes and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor prior to commencing treatment. Pregnant or lactating individuals should seek medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to track blood cell counts and liver function.

Uses of Glimitos MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glimitos MV 1mg/500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimitos MV 1mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Glimitos MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimitos MV 1mg/500mg/0.2mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimitos MV 1mg/500mg/0.2mg tablets on an empty stomach.

How Glimitos MV 1mg/500mg/0.2mg Tablet works:

One tablet of Glimitos MV (1mg/500mg/0.2mg) contains a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimitos MV 1mg/500mg/0.2mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimitos MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimitos MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Glimitos MV 1mg/500mg/0.2mg tablets carries a high risk for individuals with kidney impairment and is best avoided. Patients with severe kidney disease should definitely not take this medication. A physician's consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Glimitos MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Individuals with severe liver disease should avoid this medication. A low initial dose is typically advised for those with mild to moderate liver dysfunction. Physician consultation is recommended.

What if you forget to take Glimitos MV 1mg/500mg/0.2mg Tablet :

Should you forget to take your Glimitos MV 1mg/500mg/0.2mg Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitos MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimitos MV 1mg/500mg/0.2mg Tablet

Glimitos MV 1mg/500mg/0.2mg Tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is unsuitable for type 1 DM.
Glimitos MV 1mg/500mg/0.2mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infections.
Glimitos MV 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any ingredient. They should also not be used by individuals with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimitos MV 1mg/500mg/0.2mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimitos MV 1mg/500mg/0.2mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication safely and keep it out of reach of children, pets, and others.
Glimitos MV 1mg/500mg/0.2...
187
MRP 217
13% off